Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Pfizer Inc (PFE)

Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 151,535,328
  • Shares Outstanding, K 5,666,990
  • Annual Sales, $ 58,496 M
  • Annual Income, $ 2,119 M
  • EBIT $ 10,649 M
  • EBITDA $ 16,939 M
  • 60-Month Beta 0.65
  • Price/Sales 2.59
  • Price/Cash Flow 8.86
  • Price/Book 1.61

Options Overview Details

View History
  • Implied Volatility 23.25% ( -1.97%)
  • Historical Volatility 29.00%
  • IV Percentile 21%
  • IV Rank 35.02%
  • IV High 32.70% on 04/12/24
  • IV Low 18.16% on 05/13/24
  • Put/Call Vol Ratio 0.61
  • Today's Volume 88,285
  • Volume Avg (30-Day) 170,169
  • Put/Call OI Ratio 0.72
  • Today's Open Interest 3,277,745
  • Open Int (30-Day) 3,490,359

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.48
  • Number of Estimates 8
  • High Estimate 0.66
  • Low Estimate 0.37
  • Prior Year 0.10
  • Growth Rate Est. (year over year) +380.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
25.06 +6.70%
on 12/12/24
26.77 -0.11%
on 12/24/24
+1.09 (+4.25%)
since 11/22/24
3-Month
24.48 +9.23%
on 11/15/24
30.43 -12.13%
on 10/09/24
-2.76 (-9.36%)
since 09/24/24
52-Week
24.48 +9.23%
on 11/15/24
31.54 -15.22%
on 07/30/24
-1.66 (-5.85%)
since 12/22/23

Most Recent Stories

More News
Better Income Stock: Pfizer or Altria Group?

High-yield dividend stocks often catch investors' attention -- and for good reason. When established companies maintain larger-than-average dividend payments, they can provide both substantial current...

MO : 53.47 (-0.21%)
PFE : 26.74 (+0.11%)
Sanofi's 21-Valent Pneumococcal Vaccine Enters Phase III

Sanofi SNY and its partner SK bioscience announced that they have expanded their agreement to develop, license and commercialize next-generation pneumococcal conjugate vaccines (PCVs) for treating invasive...

PCVX : 85.91 (-1.34%)
MRK : 99.45 (+0.08%)
PFE : 26.74 (+0.11%)
SNY : 48.29 (-0.21%)
Moderna Stock Down 39% in Three Months: Buy the Dip or Wait?

Despite being a pioneer in developing one of the first and most widely used COVID-19 vaccines, shares of Moderna MRNA have been sliding down over the past few years due to waning demand for the vaccine.In...

MRK : 99.45 (+0.08%)
MRNA : 40.27 (+1.72%)
GSK : 34.03 (-0.09%)
PFE : 26.74 (+0.11%)
Got $500? This Top Dividend ETF Is a Great Buy After Its Recent Sell-Off.

Dividend stocks have gotten clobbered recently. The main catalyst is the Federal Reserve's recent decision to slow the pace of future interest rate increases. Higher rates tend to weigh on the value of...

BLK : 1,054.83 (+1.46%)
MO : 53.47 (-0.21%)
CSCO : 59.85 (+1.48%)
VZ : 39.80 (-0.35%)
CVX : 143.84 (+0.61%)
UPS : 126.26 (+0.41%)
SCHW : 74.84 (+0.17%)
SCHD : 27.58 (+0.77%)
TXN : 192.44 (+1.21%)
HD : 396.14 (+0.94%)
PFE : 26.74 (+0.11%)
BMY : 57.76 (+0.31%)
Stocking Stuffers for Income Investors: 3 Ultra-High-Yield Dividend Stocks to Buy Before the End of 2024

If you haven't finished your Christmas shopping yet, you're rapidly running out of time. I suspect many people have already purchased most of the gifts they'll give but might still have a few remaining....

EPD : 31.49 (+1.55%)
UPS : 126.26 (+0.41%)
PFE : 26.74 (+0.11%)
Love Dividends? 2 Passive Income Stocks to Scoop Up Now.

These consistent dividend-paying stocks could be a good addition to your portfolio.

ABT : 114.76 (+0.39%)
$SPX : 6,040.04 (+1.10%)
PFE : 26.74 (+0.11%)
Pfizer Just Reassured Investors, but Is the Stock a Buy?

Amid a fall season characterized by restive shareholders seeking an activist bid to unseat senior management and change the trajectory of the company, Pfizer (NYSE: PFE) is communicating that everything...

PFE : 26.74 (+0.11%)
2 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off

Stock market investors have plenty of reasons to celebrate as 2024 comes to a close. The S&P 500 index set multiple new record highs during the year, delivering a spectacular 25% return year to date amid...

ABBV : 180.00 (+0.90%)
PFE : 26.74 (+0.11%)
The Stock Market Is Historically Pricey: Here's How I'm Positioning My Portfolio for 2025

When things seem too good to be true on Wall Street, they usually are.

COMP : 6.00 (-0.50%)
TDOC : 9.26 (+1.54%)
$NASX : 20,031.13 (+1.35%)
$SPX : 6,040.04 (+1.10%)
$DOWI : 43,297.03 (+0.91%)
PFLT : 10.86 (+1.31%)
PFE : 26.74 (+0.11%)
My Top 10 Stocks to Buy for 2025

It's that time of year again. I'm not referring to buying gifts and preparing holiday meals -- although that may be part of your agenda too. It's time to look back on your portfolio's performance and plan...

NVDA : 140.22 (+0.39%)
VKTX : 42.35 (+0.07%)
CRWD : 365.79 (+1.19%)
ABT : 114.76 (+0.39%)
ETSY : 55.13 (-0.56%)
VRTX : 408.18 (+0.72%)
AXP : 303.46 (+1.56%)
AMZN : 229.05 (+1.77%)
PFE : 26.74 (+0.11%)
PLTR : 82.38 (+2.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 27.27
2nd Resistance Point 27.02
1st Resistance Point 26.88
Last Price 26.74
1st Support Level 26.49
2nd Support Level 26.24
3rd Support Level 26.10

See More

52-Week High 31.54
Fibonacci 61.8% 28.84
Fibonacci 50% 28.01
Fibonacci 38.2% 27.18
Last Price 26.74
52-Week Low 24.48

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar